Dr. Reddy’s Launches Allegra Generic
Although rival generic drug makers Barr Pharmaceuticals Inc. and Teva Pharmaceutical Industries Ltd. began marketing their versions in 2005, demand for the drug appears high enough for an at-risk launch, with Allegra generating about $1 billion in revenue last year.
Dr. Reddy's said it would immediately start marketing fexofenadine, the...
Already a subscriber? Click here to login